Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yamaura, Yu ^a   Nakajima, Miki ^a   Takagi, Shingo ^a   Fukami, Tatsuki ^a   Tsuneyama, Koichi ^b   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; MICRORNA; MICRORNA 10B; MICRORNA 122; MICRORNA 190; MICRORNA 200A; MICRORNA 327; MICRORNA 337 3P; MICRORNA 34C; MICRORNA 351; MICRORNA 410; MICRORNA 449C; MICRORNA 503; MICRORNA 704; MICRORNA 743B; RNA; UNCLASSIFIED DRUG; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LIVER CELL DAMAGE; LIVER FIBROSIS; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; NONHUMAN; RAT; SENSITIVITY AND SPECIFICITY; STEATOSIS; UPREGULATION; ADULT; ANIMAL; BLOOD; CHRONIC DISEASE; CLUSTER ANALYSIS; DISEASE MODEL; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; METABOLISM; PATHOLOGY; RNA STABILITY; SPRAGUE DAWLEY RAT; TIME;

ADULT; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTASIS; CHRONIC DISEASE; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIVER; MALE; MICRORNAS; RATS; RATS, SPRAGUE-DAWLEY; RNA STABILITY; TIME FACTORS; YOUNG ADULT;

EID: 84857166172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030250     Document Type: Article

References (32)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
3. Dillhoff M, Wojcik SE, Bloomston M, (2009) MicroRNAs in solid tumors. J Surg Res 154: 349-354.
4. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, et al. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49: 1098-1112.
5. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, et al. (2007) Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373.
6. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518.
7. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, et al. (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28: 655-661.
8. Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, et al. (2009) Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 15: 5473-5477.
9. Michael A, Bajracharya SD, Yuen PS, Zhou H, Star RA, et al. (2010) Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 16: 34-38.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
11. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
12. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, et al. (2009) Circulating miRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407.
13. Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, et al. (2009) Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 55: 1977-1983.
14. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, et al. (2010) Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 56: 1830-1838.
15. Danan G, Benichou C, (1993) Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46: 1323-1330.
16. Bénichou C, (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11: 272-276.
17. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N, (2005) Serum alanine aminotransferase in skeletal muscle diseases. Hepatology 41: 380-382.
18. Antoine DJ, Mercer AE, Williams DP, Park BK, (2009) Mechanism-based bioanalysis and biomarkers for hepatic chemical stress. Xenobiotica 39: 565-577.
19. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S, (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245: 194-205.
20. Shi Q, Hong H, Senior J, Tong W, (2010) Biomarkers for drug-induced liver injury. Expert Rev Gastroenterol Hepatol 4: 225-234.
21. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
22. Reid G, Kirschner MB, van Zandwijk N, (2010) Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol In press.
23. Gebhardt R, (1992) Metabolic zonation of the liver: Regulation and implications for liver function. Pharmacol Ther 53: 275-354.
24. Jungermann K, (1995) Zonation of metabolism and gene expression in liver. Histochem Cell Biol 103: 81-91.
25. Desmet VJ, Krstulović B, Van Damme B, (1968) Histochemical study of rat liver in alpha-naphthyl isothiocyanate (ANIT) induced cholestasis. Am J Pathol 52: 401-421.
26. Shigehara K, Yokomuro S, Ishibashi O, Mizuguchi Y, Arima Y, et al. (2011) Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One 6: e23584.
27. Jin X, Ye YF, Chen SH, Yu CH, Liu J, et al. (2009) MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease. Dig Liver Dis 41: 289-297.
28. Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, et al. (2009) MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 33: 1704-1710.
29. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, et al. (2010) Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 90: 1437-1446.
30. Li WQ, Chen C, Xu MD, Guo J, Li YM, et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J In press.
31. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, et al. (2011) The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One 6: e16081.
32. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108: 5003-5008.